Pharma Reviews: Valuations off highs but uncertainty remains in pharma sector, says Alok Dalal, CLSA

It will have an impact on existing portfolio but at the same time can benefit certain Indian companies. Also, though Indian pharma companies are ...
Read more: Valuations off highs but uncertainty remains in pharma sector, says Alok Dalal, CLSA